Thread regarding 89bio (ETNB)

Still a good choice

Yes, a few bad weeks, but overall, this is still a good choice. The company has seen its full-year earnings estimate go up by 38 percent. That means that most analysts like what they're seeing, and I couldn't agree more. The company has also managed to outperform its sector so far in the year, and that's also a huge plus. I'm in.

by
| 1 view | | no replies yet
Post ID: @OP+1jqs7hrhy

There are no replies in this thread yet. Be the first to post a reply below:

Post a reply

: